| Human papillomavirus and survival of patients with oropharyngeal cancer KK Ang, J Harris, R Wheeler, R Weber, DI Rosenthal, PF Nguyen-Tân, ... New England Journal of Medicine 363 (1), 24-35, 2010 | 6878 | 2010 |
| Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1, 3-galactose CH Chung, B Mirakhur, E Chan, QT Le, J Berlin, M Morse, BA Murphy, ... New England journal of medicine 358 (11), 1109-1117, 2008 | 1645 | 2008 |
| PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma MR Migden, D Rischin, CD Schmults, A Guminski, A Hauschild, KD Lewis, ... New England Journal of Medicine 379 (4), 341-351, 2018 | 1259 | 2018 |
| Chromosomal instability drives metastasis through a cytosolic DNA response SF Bakhoum, B Ngo, AM Laughney, JA Cavallo, CJ Murphy, P Ly, P Shah, ... Nature 553 (7689), 467-472, 2018 | 1186 | 2018 |
| Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression CH Chung, JS Parker, G Karaca, J Wu, WK Funkhouser, D Moore, ... Cancer cell 5 (5), 489-500, 2004 | 786 | 2004 |
| Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas CH Chung, K Ely, L McGavran, M Varella-Garcia, J Parker, N Parker, ... Journal of clinical oncology 24 (25), 4170-4176, 2006 | 675 | 2006 |
| Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer ML Gillison, Q Zhang, R Jordan, W Xiao, WH Westra, A Trotti, S Spencer, ... Journal of clinical oncology 30 (17), 2102, 2012 | 545 | 2012 |
| Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications CH Chung, ML Gillison Clinical cancer research 15 (22), 6758-6762, 2009 | 538 | 2009 |
| Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas Y Wang, S Springer, CL Mulvey, N Silliman, J Schaefer, M Sausen, ... Science translational medicine 7 (293), 293ra104-293ra104, 2015 | 530 | 2015 |
| Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy … PF Nguyen-Tan, Q Zhang, KK Ang, RS Weber, DI Rosenthal, D Soulieres, ... Journal of Clinical Oncology 32 (34), 3858, 2014 | 483 | 2014 |
| E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of … S Marur, S Li, AJ Cmelak, ML Gillison, WJ Zhao, RL Ferris, WH Westra, ... Journal of Clinical Oncology 35 (5), 490, 2017 | 454 | 2017 |
| p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma CH Chung, Q Zhang, CS Kong, J Harris, EJ Fertig, PM Harari, D Wang, ... Journal of clinical oncology 32 (35), 3930, 2014 | 412 | 2014 |
| Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials A Drilon, S Siena, R Dziadziuszko, F Barlesi, MG Krebs, AT Shaw, ... The Lancet Oncology 21 (2), 261-270, 2020 | 406 | 2020 |
| Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742) BBY Ma, WT Lim, BC Goh, EP Hui, KW Lo, A Pettinger, NR Foster, ... Journal of Clinical Oncology 36 (14), 1412, 2018 | 392 | 2018 |
| Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma RJC Slebos, Y Yi, K Ely, J Carter, A Evjen, X Zhang, Y Shyr, BM Murphy, ... Clinical cancer research 12 (3), 701-709, 2006 | 370 | 2006 |
| lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling Y Lu, X Zhao, Q Liu, C Li, R Graves-Deal, Z Cao, B Singh, JL Franklin, ... Nature medicine 23 (11), 1331-1341, 2017 | 356 | 2017 |
| Molecular portraits and the family tree of cancer CH Chung, PS Bernard, CM Perou Nature genetics 32 (4), 533-540, 2002 | 352 | 2002 |
| Emerging biomarkers in head and neck cancer in the era of genomics H Kang, A Kiess, CH Chung Nature reviews Clinical oncology 12 (1), 11-26, 2015 | 313 | 2015 |
| Managing premedications and the risk for reactions to infusional monoclonal antibody therapy CH Chung The oncologist 13 (6), 725-732, 2008 | 311 | 2008 |
| Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-κB signaling as characteristics of a high-risk head and neck squamous … CH Chung, JS Parker, K Ely, J Carter, Y Yi, BA Murphy, KK Ang, ... Cancer research 66 (16), 8210-8218, 2006 | 307 | 2006 |
